EXOZYMES (EXOZ) stock: insider trades, news & valuation
Health Care · Net sellingShare price and insider trades
EXOZYMES insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 1 sold $15K of EXOZ stock on the open market.
Get emailed when insiders cluster-buy stocks like EXOZ
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
EXOZ insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | $6K | 5 | — | 0 |
| Q2 2026 | — | 0 | $15K | 2 |
Valuation, profit and volume
Summary
Over the past 12 months, 0 EXOZYMES INC. insiders reported open-market purchases totaling $0, while 1 insider reported sales totaling $15K. 0 of 2 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
EXOZ stock news and SEC filings
Recent 8-K filings and headlines. Tone is scored from the headline wording; “Policy” marks regulatory, trade or government topics.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Sep 2SEC | Michael HeltzenCEO | Buy | 25014,453 held (+2%) | $7.60 | $2K | -30.9% | — |
| Sep 2SEC | Michael HeltzenCEO | Buy | 25014,203 held (+2%) | $7.52 | $2K | -30.2% | — |
| Sep 2SEC | Michael HeltzenCEO | Buy | 25114,704 held (+2%) | $7.35 | $2K | -28.6% | — |
| Sep 2SEC | Michael HeltzenCEO | Buy | 10013,953 held (+1%) | $7.50 | $750 | -30.0% | — |
| Sep 2SEC | Michael HeltzenCEO | Buy | 414,708 held (+0%) | $7.58 | $30 | -30.7% | — |
| Apr 10SEC | Tyler Paz KormanChief Scientific Officer | Sell | 750729,123 held (−0%) | $10.53 | $8K | -50.1% | — |
| Apr 10SEC | Tyler Paz KormanChief Scientific Officer | Sell | 750729,873 held (−0%) | $10.04 | $8K | -47.7% | — |
Insiders at EXOZYMES INC.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Michael HeltzenCEO | $6K | — | Sep 2, 2026 | — |
| Tyler Paz KormanChief Scientific Officer | — | $15K | Apr 10, 2026 | — |
Insider activity at other Health Care companies
Same sector, ranked by insider buying in the last 90 days.
EXOZ stock: common questions
Are EXOZYMES INC. insiders buying EXOZ stock?
In the past 12 months, 0 insiders reported open-market purchases of EXOZ worth $0. The latest was CEO Michael Heltzen bought $2K of EXOZ at $7.60.
Are EXOZYMES INC. insiders selling EXOZ stock?
1 insiders reported sales worth $15K over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is EXOZ's 52-week range?
Over the past year EXOZ has traded between $4.40 and $16.50. It last closed at $5.25 on Oct 9, 2026.